https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Quality assurance audit: a prospective non-randomised trial of chemotherapy and radiotherapy for osteolymphoma (TROG 99.04/ALLG LY02) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7373 Sat 24 Mar 2018 08:40:16 AEDT ]]> Relapse patterns after chemo-radiation for carcinoma of the oesophagus https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1829 Sat 24 Mar 2018 08:31:23 AEDT ]]> Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26599 Sat 24 Mar 2018 07:33:57 AEDT ]]> Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47360 Fri 13 Jan 2023 13:26:29 AEDT ]]>